When hospices list codes for anti-cancer and anti-emetic drugs outlined in Medicare Claims Processing Manual Chapter 17, sections 80.1.1 and 80.2.1, claims are being returned to the provider, a CMS employee tells HHL.
Among the drugs listed in those sections: Busulfan, Methotrexate, Melphalan and Trimethobenzamide Hydrochloride.
CMS recently directed Medicare Administrative Contractors to instruct hospices to remove or omit from their claims "certain" anti-cancer and anti-emetic drugs until Jan. 1. Doing so will ensure claims are paid as opposed to being returned to provider in error (
HHL 8/24/15).